DB 6 PATIENT CASE SCENARIO DEBATE

DIRECTIONS SCREEN SHOT IN SHARED FILES!!

WEEKLY READINGS:

• Goldin, D. S. (2023). Fast facts for psychopharmacology for nurse practitioners. Springer Publishing.
  • Chapter 9, “Stimulants/Neurodevelopmental Disorders” (pp. 178–208)
  • Chapter 10, “Antidementia” (pp. 208–227)
• Stahl, S. M. (2021). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press. 
  • Chapter 11, "Attention Deficit Hyperactivity Disorder and Its Treatment" (pp. 449–485)
  • Chapter 12, "Dementia: Causes, Symptomatic Treatments, and the Neurotransmitter Network Acetylcholine" (pp. 486–537)
• American Academy of Pediatrics. (2019, October). Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescentsLinks to an external site.. Pediatrics, 144(4), Article e20192528. https://doi.org/10.1542/peds.2019-2528
• Drugs.comLinks to an external site.. (2023). https://www.drugs.com/
  Note: Please use the following resource to check the most up-to-date box warnings, FDA approvals and indications, recommendations for follow-up evaluations, changes, etc.
• CHADD’s National Resource Center on ADHD. (2023). ADHD medications approved by the U.S. Food and Drug Administration: Stimulant medicationsLinks to an external site.. https://d393uh8gb46l22.cloudfront.net/wp-content/uploads/2020/02/ADHD-Medications-Approved-by-FDA-2.23.pdf
  Note: Utilize this medication table resource to familiarize yourself with the medications aligned with the topics presented this week.